-
Matrine: From Alkaloid to Mechanism-Ready Assays
2026-09-12
Matrine is a Sophora-derived alkaloid with anticancer and anti-inflammatory activity. This article develops a mechanism-ready assay framework that distinguishes cytotoxicity from stemness loss and evaluates the YTHDF1–Wnt/β-catenin hypothesis with appropriate controls.
-
Saracatinib (AZD0530): Mapping SFK Translational Biology
2026-09-11
Saracatinib (AZD0530) offers a useful experimental bridge between Src/Abl-dependent cancer biology and the Reelin–SFK signaling logic implicated in ketamine response. This article translates the mechanism into practical study design, evidence controls, and a cautious roadmap for oncology and neurobiology researchers.
-
Veratridine: Designing Better Excitotoxicity Assays
2026-09-11
Veratridine is a voltage-gated sodium channel opener that enables controlled studies of persistent depolarization, glutamate-linked injury, and sodium channel blocker activity. This article translates mechanistic findings into practical assay-design decisions while defining the limits of interpreting neuronal and cancer-cell responses.
-
Bay 11-7085: NF-κB Activation Inhibitor
2026-09-10
Bay 11-7085 is a soluble NF-κB activation inhibitor and chemical probe for TNFα-responsive signaling. Product information reports an IC50 of 10 μM for inhibition of TNFα-induced IκBα phosphorylation, while preclinical findings support applications in apoptosis, endometriosis research, neuroinflammation, and pneumococcal meningitis models.
-
EGCG: Designing Interpretable Cell Assays
2026-09-10
(-)-Epigallocatechin gallate (EGCG) is a multifunctional green tea catechin, but its assay behavior depends on stability, permeability, and model context. This guide shows how to distinguish parent-compound biology from analog-enabled effects in apoptosis, antimicrobial, antiviral, and cancer chemoprevention research.
-
γH2AX DNA Damage Detection Kit in FLASH-RT
2026-09-09
Explore how the γH2AX DNA Damage Detection Kit can translate FLASH-RT-induced DNA damage into interpretable imaging data. This guide connects radiosensitizer research with assay design, controls, and biologically cautious readout strategies.
-
Phosphatase Inhibitor Cocktail 2 Workflow
2026-09-09
Preserve phosphorylation-dependent biology from cell or tissue harvest through Western blotting, co-immunoprecipitation, imaging, and kinase assays. This practical guide pairs a 100X aqueous inhibitor with cold, low-background workflows inspired by recent chemical-proteomics findings.
-
Renal OCT2/MATE1 Inhibition by Antiemetics
2026-09-08
George and colleagues evaluated whether five 5-HT3 antagonist drugs inhibit the renal organic cation transporters OCT2 and MATE1. Their two-model in vitro design shows drug-specific inhibition of uptake and transepithelial secretion, providing a mechanistic basis for investigating transporter-mediated drug interactions involving antiemetic therapy.
-
Phebestin as a New Antiplasmodial Aminopeptidase Inhibitor
2026-09-08
The reference study identifies phebestin, a bestatin-related aminopeptidase inhibitor, as a nanomolar antiplasmodial compound active against both chloroquine-sensitive and chloroquine-resistant Plasmodium falciparum. Its integrated parasite-stage, cytotoxicity, docking, and mouse-model experiments provide a useful framework for evaluating aminopeptidase-directed malaria therapeutics while highlighting the need for direct target-validation studies.
-
SP600125: JNK Inhibitor for Mechanism-First Assays
2026-09-07
SP600125 is a reversible, ATP-competitive JNK inhibitor for connecting kinase activity with transcriptional, inflammatory, and neuronal phenotypes. This article develops a mechanism-first assay strategy using the radiation-induced neural differentiation study to clarify what SP600125 can test—and what it cannot prove.
-
Bestatin Dissects Jasmonate Signaling in Arabidopsis
2026-09-05
The reference study established bestatin as a chemical genetics probe that activates jasmonate-responsive processes through COI1-dependent signaling without requiring strictly normal jasmonate biosynthesis. By combining gene-expression analysis, developmental phenotyping, and bestatin-resistant mutant screening, it identified distinct genetic classes and candidate regulatory loci for plant defense and development.
-
Ciclesonide Workflows for Airway Inflammation Research
2026-09-05
Ciclesonide enables airway-cell experiments that distinguish prodrug activation from glucocorticoid receptor potency. This workflow guide combines practical formulation, conversion, inflammation, and mechanism controls while clarifying why emerging ERAD-degrader research should remain a separate assay track.
-
10058-F4 for c-Myc-Max Research
2026-09-04
10058-F4 gives researchers a practical way to interrogate c-Myc:Max-dependent transcription, apoptosis, differentiation, and TERT regulation. Its value is greatest when compound exposure is paired with chromatin, transcriptional, and phenotype-level readouts across leukemia, prostate cancer, and stem-cell models.
-
Nicotine Signaling and Chronic Kidney Disease: Evidence
2026-09-04
Jain and Jaimes integrate clinical observations with animal and mechanistic evidence to argue that nicotine contributes directly to chronic kidney disease progression through renal nicotinic acetylcholine receptors, reactive oxygen species, and profibrotic signaling. The review’s main practical contribution is a framework for separating nicotine-specific effects from the broader toxicology of cigarette smoke when designing kidney injury experiments.
-
GLP-1 (9-36) amide in Receptor Antagonism
2026-09-03
GLP-1 (9-36) amide provides a practical antagonist framework for separating direct GLP-1 receptor effects from ligand cross-talk in cAMP and metabolic assays. Its greatest value emerges when paired with orthogonal controls, fresh-solution handling, and the high-throughput FRET logic used to reveal nonconventional receptor activity.